Trends in nasopharyngeal carcinoma mortality in China, 1973-2005
- PMID: 22938411
- DOI: 10.7314/apjcp.2012.13.6.2495
Trends in nasopharyngeal carcinoma mortality in China, 1973-2005
Abstract
Nasopharyngeal carcinoma (NPC) is a disease with distinct ethnic and geographic distribution. The incidence of NPC in Chinese residing in Asia has declined over the last few decades, but NPC mortality trends in the entire Chinese population over time have not been systematically evaluated. In this study, we examined NPC mortality at the national level in China between 1973-2005. Mortality rates were derived from the databases of national retrospective surveys on cancer mortality conducted in the periods of 1973-1975, 1990-1992, and 2004-2005, respectively. NPC was classified according to the International classification of diseases. Age-adjusted mortality rates were calculated by direct standardization according to the world standard population. Trends in rates were evaluated by age, gender, geographic areas, and socioeconomic status. From 1973 to 2005, there was a general trend of decrease in NPC mortality in China, with higher rates in the south on a downward trend in the north. The age-standardized NPC mortality rates were 2.60 per 100,000 in 1973-1975, 1.94 per 100,000 in 1990-1992, and 1.30 per 100,000 in 2004-2005, respectively. The trend was similar in both men and women, in both urban and rural areas, but the declining rates in females were more remarkable than in males. The mortality rates were higher for the age groups above 50 years than those less than 50 years of age, both showing downward trend over 30-year period. In summary, the overall NPC mortality has consistently decreased in China over the past three decades, particularly in women and in old adults.
Similar articles
-
Nasopharyngeal carcinoma incidence and mortality in China, 2013.Chin J Cancer. 2017 Nov 9;36(1):90. doi: 10.1186/s40880-017-0257-9. Chin J Cancer. 2017. PMID: 29122009 Free PMC article.
-
Trends in incidence and mortality of nasopharyngeal carcinoma over a 20-25 year period (1978/1983-2002) in Sihui and Cangwu counties in southern China.BMC Cancer. 2006 Jul 6;6:178. doi: 10.1186/1471-2407-6-178. BMC Cancer. 2006. PMID: 16822324 Free PMC article.
-
Nasopharyngeal carcinoma incidence and mortality in China in 2010.Chin J Cancer. 2014 Aug;33(8):381-7. doi: 10.5732/cjc.014.10086. Chin J Cancer. 2014. PMID: 25096544 Free PMC article.
-
Epidemiological trends of nasopharyngeal carcinoma in China.Asian Pac J Cancer Prev. 2010;11(1):29-32. Asian Pac J Cancer Prev. 2010. PMID: 20593926 Review.
-
Histopathological classification of nasopharyngeal carcinoma.Asian Pac J Cancer Prev. 2011;12(5):1141-7. Asian Pac J Cancer Prev. 2011. PMID: 21875256 Review.
Cited by
-
Molecular pathological study of the human nasopharyngeal carcinoma CNE3 cell line.Oncol Lett. 2013 Oct;6(4):980-984. doi: 10.3892/ol.2013.1513. Epub 2013 Aug 5. Oncol Lett. 2013. PMID: 24137449 Free PMC article.
-
Effect of the vascular endothelial growth factor expression level on angiopoietin-2-mediated nasopharyngeal carcinoma growth.Vasc Cell. 2014 Mar 1;6(1):4. doi: 10.1186/2045-824X-6-4. Vasc Cell. 2014. PMID: 24581323 Free PMC article.
-
Activity and Safety of Tegafur, Gimeracil, and Oteracil Potassium for Nasopharyngeal Carcinoma: A Systematic Review and Meta-Analysis.J Oncol. 2021 Mar 23;2021:6690275. doi: 10.1155/2021/6690275. eCollection 2021. J Oncol. 2021. PMID: 33859690 Free PMC article. Review.
-
Distinctive microRNA expression in early stage nasopharyngeal carcinoma patients.J Cell Mol Med. 2016 Dec;20(12):2259-2268. doi: 10.1111/jcmm.12906. Epub 2016 Aug 4. J Cell Mol Med. 2016. PMID: 27489139 Free PMC article.
-
Nasopharyngeal carcinoma incidence and mortality in China in 2009.Chin J Cancer. 2013 Aug;32(8):453-60. doi: 10.5732/cjc.013.10118. Epub 2013 Jul 18. Chin J Cancer. 2013. PMID: 23863562 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous